{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:30:19Z","timestamp":1794634219476,"version":"4.9.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1053\/j.gastro.2025.08.029","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:06:33Z","timestamp":1760997993000},"page":"1547-1557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review"],"prefix":"10.1053","volume":"169","author":[{"given":"Eric S.","family":"Orman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Fortune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2002-9682","authenticated-orcid":false,"given":"Binu V.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet K.","family":"Asrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2025.08.029_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2468-1253(23)00438-7","article-title":"Pathophysiology and therapeutic options for cirrhotic portal hypertension","volume":"9","author":"Guix\u00e9-Muntet","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib3","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management","volume":"48","author":"Gin\u00e8s","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/gast.2001.21193","article-title":"Factors associated with poor health-related quality of life of patients with cirrhosis","volume":"120","author":"Marchesini","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.029_bib5","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/hep.29756","article-title":"Patient-reported outcomes in cirrhosis: a scoping review of the literature","volume":"67","author":"Tapper","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","article-title":"Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema","volume":"57","author":"Sol\u00e0","year":"2012","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.12788\/jhm.2967","article-title":"Hospital readmissions in patients with cirrhosis: a systematic review","volume":"13","author":"Orman","year":"2018","journal-title":"J Hosp Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib8","doi-asserted-by":"crossref","first-page":"e1426","DOI":"10.1016\/j.cgh.2021.07.032","article-title":"Patient-reported outcome measures modestly enhance prediction of readmission in patients with cirrhosis","volume":"20","author":"Orman","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10620-018-4990-y","article-title":"Mortality from spontaneous bacterial peritonitis among hospitalized patients in the USA","volume":"63","author":"Niu","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.029_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001625","article-title":"Differential effects of ascites and hepatic encephalopathy on waitlist mortality in liver transplantation by MELD 3.0","volume":"10","author":"Lee","year":"2024","journal-title":"Transplant Direct"},{"key":"10.1053\/j.gastro.2025.08.029_bib12","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis","volume":"104","author":"Guevara","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.029_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2008.176495","article-title":"Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial","volume":"59","author":"Angeli","year":"2010","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.08.029_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-8278(03)00188-0","article-title":"Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety","volume":"39","author":"Santos","year":"2003","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib18","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/0016-5085(92)91730-R","article-title":"Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites","volume":"102","author":"Sungaila","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.029_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2013.08.025","article-title":"Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites","volume":"12","author":"Orman","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib20","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.14309\/ajg.0000000000002906","article-title":"Early paracentesis improves outcomes of hospitalized patients with cirrhosis and ascites: a systematic review and meta-analysis","volume":"119","author":"Beran","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.029_bib21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/HEP.0000000000000577","article-title":"Refractory hepatic hydrothorax is associated with increased mortality with death occurring at lower MELD-Na compared to cirrhosis and refractory ascites","volume":"79","author":"Chin","year":"2024","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib22","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.mayocp.2018.12.036","article-title":"Prevalence and predictors of third-generation cephalosporin resistance in the empirical treatment of spontaneous bacterial peritonitis","volume":"94","author":"Sunjaya","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.gastro.2025.08.029_bib23","article-title":"Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2025.08.029_bib24","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/ajt.12762","article-title":"Frailty predicts waitlist mortality in liver transplant candidates","volume":"14","author":"Lai","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1053\/j.gastro.2025.08.029_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2016.03.036","article-title":"Poor performance status is associated with increased mortality in patients with cirrhosis","volume":"14","author":"Orman","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib26","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/ajt.15392","article-title":"Frailty in liver transplantation: an expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice","volume":"19","author":"Lai","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1053\/j.gastro.2025.08.029_bib27","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: The Model for End-Stage Liver Disease Updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.029_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/lt.22218","article-title":"Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk","volume":"17","author":"Somsouk","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2025.08.029_bib29","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1007\/s10620-022-07522-8","article-title":"Refractory hepatic hydrothorax is an independent predictor of mortality when compared to refractory ascites","volume":"67","author":"Osman","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.029_bib30","series-title":"Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exception Review","year":"2023"},{"key":"10.1053\/j.gastro.2025.08.029_bib31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib32","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0168-8278(05)80070-4","article-title":"Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study","volume":"20","author":"Sol\u00e0","year":"1994","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0016-5085(90)91303-N","article-title":"Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites","volume":"98","author":"Tit\u00f3","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.029_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.029_bib36","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027431","article-title":"Prevalence, risk factors, and short-term outcomes of postparacentesis acute kidney injury using revised criteria of the international club of ascites","volume":"100","author":"Shin","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.gastro.2025.08.029_bib37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.31071","article-title":"Paracentesis-induced circulatory dysfunction with modest-volume paracentesis is partly ameliorated by albumin infusion in acute-on-chronic liver failure","volume":"72","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.20317","article-title":"Performance standards for therapeutic abdominal paracentesis","volume":"40","author":"Grabau","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2005.02387.x","article-title":"Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease","volume":"21","author":"Pache","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.08.029_bib40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/HEP.0000000000000856","article-title":"Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: persistent gaps and areas of consensus in a multispecialty Delphi","volume":"80","author":"Tapper","year":"2024","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000490001","article-title":"Repeat thoracentesis in hepatic hydrothorax and non-hepatic hydrothorax effusions: a case-control study","volume":"96","author":"Shojaee","year":"2018","journal-title":"Respiration"},{"key":"10.1053\/j.gastro.2025.08.029_bib42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s12072-009-9136-z","article-title":"Outcomes of patients with chest tube insertion for hepatic hydrothorax","volume":"3","author":"Orman","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2025.08.029_bib43","article-title":"Efficacy and safety of indwelling pleural catheters in management of hepatic hydrothorax: a systematic review of literature","volume":"10","author":"Baig","year":"2018","journal-title":"Cureus"},{"key":"10.1053\/j.gastro.2025.08.029_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.chest.2018.07.001","article-title":"Indwelling pleural catheters in hepatic hydrothorax: a single-center series of outcomes and complications","volume":"155","author":"Kniese","year":"2019","journal-title":"Chest"},{"key":"10.1053\/j.gastro.2025.08.029_bib45","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib46","first-page":"881","article-title":"Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study","volume":"43","author":"Alessandria","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2025.08.029_bib47","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s10620-015-3578-z","article-title":"Reduced albumin dosing during large-volume paracentesis is not associated with adverse clinical outcomes","volume":"60","author":"Johnson","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.029_bib48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/HEP.0000000000000530","article-title":"AASLD guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.029_bib50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular Intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.029_bib51","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.20840","article-title":"Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy","volume":"42","author":"Campbell","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib52","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jhep.2014.01.015","article-title":"Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial","volume":"60","author":"Perarnau","year":"2014","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib53","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.32596","article-title":"The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: recent evolution and open questions","volume":"77","author":"Deltenre","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib54","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American Practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension","volume":"20","author":"Boike","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib55","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/M20-0202","article-title":"The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt : a randomized controlled trial","volume":"174","author":"Bureau","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib56","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jhep.2021.01.023","article-title":"Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival","volume":"74","author":"Bettinger","year":"2021","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.32704","article-title":"Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: a validated prediction model","volume":"77","author":"Vizzutti","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib58","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.cgh.2018.03.027","article-title":"Cost effectiveness of early insertion of transjugular intrahepatic portosystemic shunts for recurrent ascites","volume":"16","author":"Shen","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib59","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MEG.0000000000000837","article-title":"Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis","volume":"29","author":"Solbach","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib61","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.14162","article-title":"Permanent indwelling peritoneal catheters for palliation of refractory ascites in end-stage liver disease: a systematic review","volume":"39","author":"Macken","year":"2019","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2025.08.029_bib62","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2017.06.010","article-title":"Alfapump system vs. large volume paracentesis for refractory ascites: a multicenter randomized controlled study","volume":"67","author":"Bureau","year":"2017","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib63","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/lt.25724","article-title":"Improvement in quality of life and decrease in large-volume paracentesis requirements with the automated low-flow ascites pump","volume":"26","author":"Wong","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2025.08.029_bib64","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.dld.2021.12.007","article-title":"Current treatment options of refractory ascites in liver cirrhosis - a systematic review and meta-analysis","volume":"54","author":"Will","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2025.08.029_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40261-022-01147-5","article-title":"Management of liver decompensation in advanced chronic liver disease: ascites, hyponatremia, and gastroesophageal variceal bleeding","volume":"42","author":"Baiges","year":"2022","journal-title":"Clin Drug Investig"},{"key":"10.1053\/j.gastro.2025.08.029_bib66","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/lt.24085","article-title":"Use of serum sodium for liver transplant graft allocation: a decade in the making, now is it ready for primetime?","volume":"21","author":"Biggins","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2025.08.029_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jceh.2021.09.008","article-title":"Clinical , evaluation, and management of hyponatremia in cirrhosis","volume":"12","author":"Praharaj","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib69","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib70","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gut.31.2.204","article-title":"Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites","volume":"31","author":"McCormick","year":"1990","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.08.029_bib71","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41395-018-0119-3","article-title":"The impact of albumin use on resolution of hyponatremia in hospitalized patients with cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.029_bib72","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2025.08.029_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.07.033","article-title":"Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis","volume":"62","author":"Ahluwalia","year":"2015","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11011-010-9172-3","article-title":"Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence","volume":"25","author":"C\u00f3rdoba","year":"2010","journal-title":"Metab Brain Dis"},{"key":"10.1053\/j.gastro.2025.08.029_bib75","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib76","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib77","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"170","author":"Spasovski","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.gastro.2025.08.029_bib78","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2025.08.029_bib79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.amjmed.2016.09.011","article-title":"Limited efficacy of tolvaptan in patients with cirrhosis and severe hyponatremia: real-life experience","volume":"130","author":"Pose","year":"2017","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib80","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","article-title":"Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis","volume":"56","author":"C\u00e1rdenas","year":"2012","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib81","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","article-title":"Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial","volume":"48","author":"Gines","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib82","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/lt.25327","article-title":"Hyponatremia in cirrhosis: implications for liver transplantation","volume":"24","author":"Leise","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2025.08.029_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1579508","article-title":"Management strategies and outcomes for hyponatremia in cirrhosis in the hyponatremia registry","volume":"2018","author":"Sigal","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib84","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.gastro.2023.10.016","article-title":"clinical practice update on the use of vasoactive drugs and intravenous albumin in cirrhosis: expert review","volume":"166","author":"Garcia-Tsao","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.029_bib85","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/eurjhf\/hft097","article-title":"Salt and fluid restriction is effective in patients with chronic heart failure","volume":"15","author":"Philipson","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.gastro.2025.08.029_bib86","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib87","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1185\/03007997709115292","article-title":"Treatment of fluid retention in cirrhosis: a comparison of bumetanide and frusemide","volume":"4","author":"Nicholson","year":"1977","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/j.gastro.2025.08.029_bib88","first-page":"180","article-title":"Comparative pharmacodynamics of torasemide and furosemide in patients with oedema","volume":"38","author":"Herchuelz","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1053\/j.gastro.2025.08.029_bib89","doi-asserted-by":"crossref","first-page":"32","DOI":"10.59556\/japi.72.0675","article-title":"Torsemide in edema associated with hepatic impairment","volume":"72","author":"Upadhyay","year":"2024","journal-title":"J Assoc Physicians India"},{"key":"10.1053\/j.gastro.2025.08.029_bib90","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5603\/CJ.a2019.0114","article-title":"Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: preliminary results from the randomized TORNADO trial","volume":"26","author":"Balsam","year":"2019","journal-title":"Cardiol J"},{"key":"10.1053\/j.gastro.2025.08.029_bib91","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.3390\/jcm13154470","article-title":"Diuretic treatment in heart failure: a practical guide for clinicians","volume":"13","author":"Wu","year":"2024","journal-title":"J Clin Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib92","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12664-023-01475-0","article-title":"Human albumin infusion is safe and effective even in patients without acute kidney injury and spontaneous bacterial peritonitis","volume":"43","author":"Kulkarni","year":"2024","journal-title":"Indian J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.029_bib93","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/HEP.0000000000000521","article-title":"Controversies regarding albumin therapy in cirrhosis","volume":"81","author":"Trebicka","year":"2025","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib94","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib95","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib96","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.28558","article-title":"Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis","volume":"64","author":"Kanwal","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.029_bib97","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","article-title":"Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting","volume":"81","author":"Nadim","year":"2024","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.029_bib98","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.amjmed.2021.09.016","article-title":"Attendance at a transitional liver clinic may be associated with reduced readmissions for patients with liver disease","volume":"135","author":"Yoder","year":"2022","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2025.08.029_bib99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12325-012-0073-1","article-title":"Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis","volume":"30","author":"Deitelzweig","year":"2013","journal-title":"Adv Ther"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525059591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525059591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:14:26Z","timestamp":1776917666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508525059591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0016508525059591"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2025.08.029","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2025.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}